Test Price
800 AED✅ Home Collection Available
Factor VIII Functional Activity Test in UAE – 800 AED – DHA Licensed Lab
Executive Summary & Core Metrics
Executive Summary – Factor VIII Functional Activity Test
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited electromechanical clot detection.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) covering all UAE emirates.
- Clinical Guidance: Telephonic post‑test result interpretation by a General Practitioner (DHA‑licensed).
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 before the draw.
Test Overview & Methodology
The Factor VIII functional activity assay quantifies the clotting ability of factor VIII, a critical protein in the intrinsic coagulation cascade. It is the gold‑standard screening tool for hemophilia A, acquired factor VIII deficiency, and monitoring of replacement therapy.
| Feature | Our Test (Electromechanical Clot Detection) | Closest Alternative (Chromogenic/ELISA) |
|---|---|---|
| Precision (CV) | <3 % intra‑assay | 5–10 % |
| Methodology | Electromechanical clot endpoint – direct functional readout | Chromogenic substrate – indirect activity measurement |
| Turnaround Time | Same‑day (sample by 11 am) | 24–48 hours |
| Interference | Minimal with standard heparin/LMWH | Can be affected by color/turbidity |
Physician Insight & Safety Protocols
“Factor VIII activity must be interpreted alongside patient history, bleeding phenotype, and concurrent conditions. A single normal result does not exclude mild hemophilia, while low activity in the absence of bleeding may indicate a pre‑analytical error or an acquired inhibitor. I always recommend repeat testing and comprehensive coagulation work‑up before initiating lifelong therapy.”
— Dr. Ajay Singh, General Practitioner, DHA License 36234132
Medication Safety Advisory
Do not discontinue prescribed heparin or oral anticoagulants without explicit consent from your treating physician. Abrupt cessation can precipitate life‑threatening thrombosis. Always consult your doctor before making any changes to medication.
Patient Exclusion Criteria & Emergency Red Flags
- Active severe bleeding – emergency care takes priority; test should be postponed.
- Known high‑titre factor VIII inhibitor (risk of anamnestic rise after testing).
- Inability to tolerate venipuncture or required 3 mL citrated blood draw (consult pediatric hematology for micro‑volume protocols).
- Patient on heparin or warfarin without a 1‑day (heparin) / 7‑day (warfarin) washout, unless ordered by the specialist.
- ER Red Flags: Sudden severe headache, hematuria, melena, joint swelling, or unrelenting epistaxis – go to the nearest emergency department immediately; do not wait for test results.
Patient FAQ & Clinical Guidance
1. What is the Factor VIII activity test used for?
A: The test measures the clotting ability of factor VIII to diagnose hemophilia A, monitor replacement therapy, and detect acquired inhibitors.
2. How should I prepare for the test?
A: Fast overnight, fill the coagulation requisition form, and – with your doctor’s approval – stop heparin 1 day and warfarin 7 days before the draw.
3. What do the results mean?
A: A low activity (<40 %) suggests factor VIII deficiency, while a normal result does not rule out mild hemophilia – clinical correlation is essential.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Security: This service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Accreditation: ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139). Laboratory License: 9834453.
Clinical & Logistical Metadata
| Test Name | Factor VIII Functional Activity Test |
| Price (AED) | 800 |
| Turnaround Time | Same‑day (sample by 11 AM) |
| Sample Type / Matrix | Peripheral whole blood (3.2% sodium citrate) |
| Methodology Used | Electromechanical clot detection |
| ICD-10-CM Code | D66 (Hereditary factor VIII deficiency) |
| LOINC Code | 3209-7 |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians